Literature DB >> 7873324

Multiple disease genes cause hypertrophic cardiomyopathy.

H Watkins1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7873324      PMCID: PMC1025668          DOI: 10.1136/hrt.72.6_suppl.s4

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  43 in total

1.  Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history.

Authors:  S Frank; E Braunwald
Journal:  Circulation       Date:  1968-05       Impact factor: 29.690

2.  Hypertrophic cardiomyopathy: a discussion of nomenclature.

Authors:  B J Maron; S E Epstein
Journal:  Am J Cardiol       Date:  1979-06       Impact factor: 2.778

3.  Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients.

Authors:  H Yamaguchi; T Ishimura; S Nishiyama; F Nagasaki; S Nakanishi; F Takatsu; T Nishijo; T Umeda; K Machii
Journal:  Am J Cardiol       Date:  1979-09       Impact factor: 2.778

4.  Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography.

Authors:  B J Maron; P F Nichols; L W Pickle; Y E Wesley; J J Mulvihill
Journal:  Am J Cardiol       Date:  1984-04-01       Impact factor: 2.778

5.  Heterogeneous morphologic expression of genetically transmitted hypertrophic cardiomyopathy. Two-dimensional echocardiographic analysis.

Authors:  E Ciró; P F Nichols; B J Maron
Journal:  Circulation       Date:  1983-06       Impact factor: 29.690

6.  Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients.

Authors:  B J Maron; J S Gottdiener; S E Epstein
Journal:  Am J Cardiol       Date:  1981-09       Impact factor: 2.778

7.  Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features.

Authors:  W McKenna; J Deanfield; A Faruqui; D England; C Oakley; J Goodwin
Journal:  Am J Cardiol       Date:  1981-03       Impact factor: 2.778

8.  Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study.

Authors:  L M Shapiro; W J McKenna
Journal:  J Am Coll Cardiol       Date:  1983-09       Impact factor: 24.094

9.  "Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death.

Authors:  B J Maron; L C Lipson; W C Roberts; D D Savage; S E Epstein
Journal:  Am J Cardiol       Date:  1978-06       Impact factor: 2.778

10.  A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3.

Authors:  H Watkins; C MacRae; L Thierfelder; Y H Chou; M Frenneaux; W McKenna; J G Seidman; C E Seidman
Journal:  Nat Genet       Date:  1993-04       Impact factor: 38.330

View more
  5 in total

1.  Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.

Authors:  Amelie Burghardt; Frank van Buuren; Zisis Dimitriadis; Tim Grübbel; Hubert Seggewiss; Smita Scholtz; Dieter Horstkotte; Lothar Faber
Journal:  Clin Res Cardiol       Date:  2018-02-16       Impact factor: 5.460

2.  A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants.

Authors:  J R Skinner; A Manzoor; A M Hayes; H S Joffe; R P Martin
Journal:  Heart       Date:  1997-03       Impact factor: 5.994

3.  A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy.

Authors:  Q Yang; A Sanbe; H Osinska; T E Hewett; R Klevitsky; J Robbins
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

4.  Cardiopulmonary responses to exercise in patients with hypertrophic cardiomyopathy.

Authors:  S Jones; P M Elliott; S Sharma; W J McKenna; B J Whipp
Journal:  Heart       Date:  1998-07       Impact factor: 5.994

5.  Genetic screening in hereditary multiple endocrine neoplasia type 1: absence of a founder effect among Japanese families.

Authors:  A Sakurai; M Katai; Y Itakura; K Nakajima; K Baba; K Hashizume
Journal:  Jpn J Cancer Res       Date:  1996-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.